Online Reporting of Adverse Drug Reactions: A Study from a French Regional Pharmacovigilance Center
Therapie, 69 5 (2014) 395-400
Publié en ligne : 2014-10-01
Article cité par
La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).
Article cité :
Citations de cet article :
Evaluation of a self-screening tool and patient alert cards to help patients identify and manage severe adverse drug reactions
Warisara Srisuriyachanchai, Chingching Foocharoen, Ajanee Mahakkanukrauh, Anthony R. Cox and Narumol JarernsiripornkulInternational Journal of Clinical Pharmacy 47 (3) 726 (2025)
https://doi.org/10.1007/s11096-025-01864-9
(2024)
https://doi.org/10.21203/rs.3.rs-4998732/v1
Evaluation of a simplified pharmacovigilance tool for general practitioners: 5 years of insight
A. Trenque, A. Rabiaza, S. Fedrizzi, B. Chretien, M. Sassier, R. Morello, J. Alexandre and X. HumbertScientific Reports 14 (1) (2024)
https://doi.org/10.1038/s41598-024-51753-w
Effectiveness of the modified TaWai mobile application for reporting adverse drug reaction in Lao PDR: a cluster randomized controlled trial
Niphonh Mongkhonmath, Phayom Sookaneknun Olson, Panupong Puttarak, Soulyvanh Keokinnaly and Ratree SawangjitScientific Reports 14 (1) (2024)
https://doi.org/10.1038/s41598-024-82474-9
Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update
Patricia García-Abeijon, Catarina Costa, Margarita Taracido, Maria Teresa Herdeiro, Carla Torre and Adolfo FigueirasDrug Safety 46 (7) 625 (2023)
https://doi.org/10.1007/s40264-023-01302-7
Cabinets de médecine générale et notification des effets indésirables médicamenteux : expertise d’un délégué de l’Assurance maladie
Sophie Fedrizzi, Basile Chrétien, Marion Sassier, Philippe Decaen, Mehedi Paul, Joachim Alexandre and Xavier HumbertSanté Publique Vol. 34 (6) 795 (2023)
https://doi.org/10.3917/spub.226.0795
A new paradigm in adverse drug reaction reporting: consolidating the evidence for an intervention to improve reporting
Raymond Li, Kate Curtis, Syed Tabish Zaidi, Connie Van and Ronald CastelinoExpert Opinion on Drug Safety 21 (9) 1193 (2022)
https://doi.org/10.1080/14740338.2022.2118712
Public-private partnership (3Ps) in ensuring safe use of medicines: An Indian experience
Vivekanandan Kalaiselvan, Shatrunajay Shukla, Shubhang Arora, Tarani Prakash Shrivastava and Rajeev Singh RaghuvanshiFrontiers in Public Health 10 (2022)
https://doi.org/10.3389/fpubh.2022.930696
Effectiveness of the Med Safety mobile application in improving adverse drug reaction reporting by healthcare professionals in Uganda: a protocol for a pragmatic cluster-randomised controlled trial
Ronald Kiguba, Norah Mwebaza, Ronald Ssenyonga, Helen Byomire Ndagije, Victoria Nambasa, Cordelia Katureebe, Kenneth Katumba, Phil Tregunno, Kendal Harrison, Charles Karamagi, Kathryn A Scott and Munir PirmohamedBMJ Open 12 (7) e061725 (2022)
https://doi.org/10.1136/bmjopen-2022-061725
Assessment of Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting Among Healthcare Professionals working in Primary, Secondary and Tertiary Healthcare Facilities in Ekiti State, South-West Nigeria
Theophilus A. Adegbuyi, Joseph O. Fadare, Ebisola J. Araromi, Abayomi O. Sijuade, Iyanu Bankole, Ilesanmi K. Fasuba and Rachel A. AlabiHospital Pharmacy 56 (6) 751 (2021)
https://doi.org/10.1177/0018578720957968
Pharmacovigilance: Perspectives in India
Dr Novy Gupte and Sapna PradhanJournal of Medical Academics 3 (2) 59 (2021)
https://doi.org/10.5005/jp-journals-10070-0062
Interventions to improve adverse drug reaction reporting: A scoping review
Malahat Khalili, Bita Mesgarpour, Hamid Sharifi, Samira Daneshvar Dehnavi and Ali Akbar HaghdoostPharmacoepidemiology and Drug Safety 29 (9) 965 (2020)
https://doi.org/10.1002/pds.4966
Effectiveness of interventions to improve adverse drug reaction reporting by healthcare professionals over the last decade: A systematic review
Raymond Li, Syed Tabish Razi Zaidi, Timothy Chen and Ronald CastelinoPharmacoepidemiology and Drug Safety 29 (1) 1 (2020)
https://doi.org/10.1002/pds.4906
Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions
Rubina Mulchandani and Ashish Kumar KakkarInternational Journal of Risk & Safety in Medicine 30 (1) 33 (2019)
https://doi.org/10.3233/JRS-180025
L’activité de recueil des centres régionaux de pharmacovigilance est-elle influée par des déterminants régionaux démographiques ou sanitaires ?
Laurent Lam, Christelle Desitter and Patrick MaisonTherapies 74 (3) 333 (2019)
https://doi.org/10.1016/j.therap.2018.05.002
Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP®: A Comparison with Classical Methods of Reporting
François Montastruc, Haleh Bagheri, Isabelle Lacroix, et al.Drug Safety 41 (5) 511 (2018)
https://doi.org/10.1007/s40264-017-0630-2
Barriers to the success of an electronic pharmacovigilance reporting system in Kenya: an evaluation three years post implementation
Oscar O Agoro, Sarah W Kibira, Jenny V Freeman and Hamish S F FraserJournal of the American Medical Informatics Association 25 (6) 627 (2018)
https://doi.org/10.1093/jamia/ocx102
Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon
Aline Hajj, Souheil Hallit, Elsy Ramia and Pascale SalamehCurrent Medical Research and Opinion 34 (1) 149 (2018)
https://doi.org/10.1080/03007995.2017.1361916
Apport de la visite d’assistants de recherche clinique aux cabinets de médecins généralistes sur la notification des effets indésirables médicamenteux
Geneviève Durrieu, Julien Jacquot, Dominique Baudrin, et al.Therapies 72 (3) 351 (2017)
https://doi.org/10.1016/j.therap.2016.09.004
Pharmacoepidemiology and its input to pharmacovigilance
Jean-Luc Faillie, François Montastruc, Jean-Louis Montastruc and Antoine ParienteTherapies 71 (2) 211 (2016)
https://doi.org/10.1016/j.therap.2016.02.016
Patient Participation and the Use of Ehealth Tools for Pharmacoviligance
Joëlle Berrewaerts, Laure Delbecque, Pierre Orban and Martin DesseillesFrontiers in Pharmacology 7 (2016)
https://doi.org/10.3389/fphar.2016.00090
How to promote adverse drug reaction reports using information systems – a systematic review and meta-analysis
Inês Ribeiro-Vaz, Ana-Marta Silva, Cristina Costa Santos and Ricardo Cruz-CorreiaBMC Medical Informatics and Decision Making 16 (1) (2016)
https://doi.org/10.1186/s12911-016-0265-8
L’apport de la pharmaco-épidémiologie à la pharmacovigilance
Jean-Luc Faillie, François Montastruc, Jean-Louis Montastruc and Antoine ParienteTherapies 71 (2) 203 (2016)
https://doi.org/10.1016/j.therap.2016.02.015
Promoting adverse drug reaction reporting: comparison of different approaches
Inês Ribeiro-Vaz, Cristina Costa Santos and Ricardo Cruz-CorreiaRevista de Saúde Pública 50 (2016)
https://doi.org/10.1590/S1518-8787.2016050006122
Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study
Geneviève Durrieu, Julien Jacquot, Mathilde Mège, et al.Drug Safety 39 (12) 1189 (2016)
https://doi.org/10.1007/s40264-016-0463-4
Bisphosphonate‐related osteonecrosis of the jaw: data from the French national pharmacovigilance database
Paul de Boissieu, Louise Gaboriau, Aurore Morel and Thierry TrenqueFundamental & Clinical Pharmacology 30 (5) 450 (2016)
https://doi.org/10.1111/fcp.12211